Related Experiment Video
Updated: Apr 15, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
Published on: December 10, 2012
Sparse Bayesian Graphical Models for RPPA Time Course Data
Riten Mitra1, Peter Mueller2, Yuan Ji3
1ICES, University of Texas at Austin, rmitra1@math.utexas.edu.
Abstract:
Advances in functional proteomic technologies have significantly enriched our knowledge of protein functions and their interactions in bio-molecular pathways. We discuss inference for RPPA (reverse phase protein array) data that measure the expression of the protein markers over time. We exploit the dynamical nature of the experiment to build a directed network of protein interactions. For this, we employ a Bayesian graphical model with an informative prior that favors sparsity. Conditional on the network, we model dependence at the level of latent binary indicators rather than the raw expression measurements. One of the key features of the proposed approach is a hierarchical model that allows for the dependence structure to be shared across different experiments, in the case of the motivating application across different drugs and doses. This is critical to facilitate meaningful inference with the limited available sample sizes. The second key feature is a sparsity inducing prior on the dependence structure. We show an application of the method to data measuring abundance of phosphorylated proteins in a human ovarian cell line.
More Related Videos
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

